Cargando…

CXCR3+ T cells in multiple sclerosis correlate with reduced diversity of the gut microbiome

Multiple sclerosis (MS) is a genetically mediated autoimmune disease characterized by inflammation in the central nervous system (CNS). Disease onset is thought to occur when autoreactive T cells orchestrate a cascade of events in the CNS resulting in white and grey matter inflammation and axonal de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choileáin, Siobhán Ní, Kleinewietfeld, Markus, Raddassi, Khadir, Hafler, David A., Ruff, William E., Longbrake, Erin E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388357/ https://www.ncbi.nlm.nih.gov/pubmed/32743517 http://dx.doi.org/10.1016/j.jtauto.2019.100032

Ejemplares similares

Impaired TIGIT expression on B cells drives circulating follicular helper T cell expansion in multiple sclerosis
por: Asashima, Hiromitsu, et al.
Publicado: (2022)

PD-1(high)CXCR5(–)CD4(+) peripheral helper T cells promote CXCR3(+) plasmablasts in human acute viral infection
por: Asashima, Hiromitsu, et al.
Publicado: (2023)

Interrelation of Diet, Gut Microbiome, and Autoantibody Production
por: Petta, Ioanna, et al.
Publicado: (2018)

Prior cycles of anti-CD20 antibodies affect antibody responses after repeated SARS-CoV-2 mRNA vaccination
por: Asashima, Hiromitsu, et al.
Publicado: (2023)

Single-Cell Multiomics Analysis for Drug Discovery
por: Nassar, Sam F., et al.
Publicado: (2021)

An older dog with newer tricks: Predicting efficacy of IFN-β treatment for multiple sclerosis
por: Wu, Gregory F., et al.
Publicado: (2016)

Gut Microbiome Wellness Index 2 for Enhanced Health Status Prediction from Gut Microbiome Taxonomic Profiles
por: Chang, Daniel, et al.
Publicado: (2023)

Gut Microbiota and the Paradox of Cancer Immunotherapy
por: Poutahidis, Theofilos, et al.
Publicado: (2014)

Functional differences between PD-1(+) and PD-1(-) CD4(+) effector T cells in healthy donors and patients with glioblastoma multiforme
por: Goods, Brittany A., et al.
Publicado: (2017)

Seroconversion after COVID-19 vaccination for multiple sclerosis patients on high efficacy disease modifying medications
por: Levit, Elle, et al.
Publicado: (2022)

Efficacy and tolerability of oral versus injectable disease-modifying therapies for multiple sclerosis in clinical practice
por: Longbrake, Erin E, et al.
Publicado: (2016)

Differential expression of the T-cell inhibitor TIGIT in glioblastoma and MS
por: Lucca, Liliana E., et al.
Publicado: (2020)

Gut microbiome alpha-diversity is not a marker of Parkinson’s disease and multiple sclerosis
por: Plassais, Jonathan, et al.
Publicado: (2021)

Monocyte:T cell interaction regulates human T cell activation through a CD28/CD46 crosstalk
por: Charron, Lauren, et al.
Publicado: (2015)

Precision Medicine: Steps along the Road to Combat Human Cancer
por: Nassar, Samuel F., et al.
Publicado: (2020)

Circulating clonally expanded T cells reflect functions of tumor-infiltrating T cells
por: Lucca, Liliana E., et al.
Publicado: (2021)

High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing–Remitting Multiple Sclerosis
por: Freeman, Léorah, et al.
Publicado: (2022)

Antibiotic Resistance Gene Diversity and Virulence Gene Diversity Are Correlated in Human Gut and Environmental Microbiomes
por: Escudeiro, Pedro, et al.
Publicado: (2019)

Calcitriol Modulates the CD46 Pathway in T Cells
por: Kickler, Karoline, et al.
Publicado: (2012)

Alterations of the human gut microbiome in multiple sclerosis
por: Jangi, Sushrut, et al.
Publicado: (2016)

The Role of Diet and Gut Microbiome in Multiple Sclerosis
por: Jayasinghe, Maleesha, et al.
Publicado: (2022)

Feeding the gut microbiome: impact on multiple sclerosis
por: Bronzini, Matteo, et al.
Publicado: (2023)

Reduced Mass and Diversity of the Colonic Microbiome in Patients with Multiple Sclerosis and Their Improvement with Ketogenic Diet
por: Swidsinski, Alexander, et al.
Publicado: (2017)

Challenges and opportunities of strain diversity in gut microbiome research
por: Anderson, Benjamin D., et al.
Publicado: (2023)

ScRNA-seq defines dynamic T-cell subsets in longitudinal colon and peripheral blood samples in immune checkpoint inhibitor-induced colitis
por: Mann, Jacqueline E, et al.
Publicado: (2023)

Host Genetics and Gut Microbiome: Perspectives for Multiple Sclerosis
por: Maglione, Alessandro, et al.
Publicado: (2021)

Gut microbiome is associated with multiple sclerosis activity in children
por: Horton, Mary K., et al.
Publicado: (2021)

Alterations of host-gut microbiome interactions in multiple sclerosis
por: Cantoni, Claudia, et al.
Publicado: (2022)

Fasting alters the gut microbiome reducing blood pressure and body weight in metabolic syndrome patients
por: Maifeld, András, et al.
Publicado: (2021)

Gut microbiome diversity and composition is associated with hypertension in women
por: Louca, Panayiotis, et al.
Publicado: (2021)

Single-cell immunophenotyping of the skin lesion erythema migrans identifies IgM memory B cells
por: Jiang, Ruoyi, et al.
Publicado: (2021)

Dietary effects on human gut microbiome diversity
por: Xu, Zhenjiang, et al.
Publicado: (2015)

The Dynamic Processing of CD46 Intracellular Domains Provides a Molecular Rheostat for T Cell Activation
por: Ni Choileain, Siobhan, et al.
Publicado: (2011)

Gut Microbiome Diversity and Abundance Correlate with Gray Matter Volume (GMV) in Older Adults with Depression
por: Lee, Sungeun Melanie, et al.
Publicado: (2022)

Gut microbiome in multiple sclerosis: The players involved and the roles they play
por: Shahi, Shailesh K., et al.
Publicado: (2017)

The Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic Avenue
por: Kirby, Trevor O., et al.
Publicado: (2018)

The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients
por: Zeng, Qianqian, et al.
Publicado: (2020)

Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes
por: Reynders, Tatjana, et al.
Publicado: (2020)

Gut microbiome in systemic sclerosis: a potential therapeutic target
por: Polkowska-Pruszyńska, Beata, et al.
Publicado: (2020)

The gut microbiome molecular mimicry piece in the multiple sclerosis puzzle
por: Elsayed, Noha S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pa6jjqv114601io2o7mkf396rq